Call has ended!
The European Partnership for Personalized Medicine (EP PerMed) partnership launched in January. More than 50 partners and financing organizations from different EU countries are involved in the partnership. In Finland, Business Finland and the Academy of Finland participate in the funding.
The first application of the ten-year program period, Joint Transnational Call (JTC2024) “Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)”, has opened in January. The preliminary budget for the application is approximately €45 million, of which Business Finland's grant budget is at most €3 million.
The goal of EP PerMed is to finance research that promotes the identification or validation of targets for individualized medical approaches. In the first application for a partnership, applicants must combine the research of new and advanced targets with biomarker research (companion diagnostics). Consortia are required to be international, interdisciplinary and cross-sector. The application for intent must clearly state the personalized medicine perspective of the planned research.
Aim of the call
The EP PerMed JTC2024 is co-funded by the EU and the overall objectives of the JTC2024 are to:
- Support research projects in human health aiming at identifying or validating targets for personalised medicine approaches in combination with development of companion biomarkers or other markers to allow for monitoring of treatment outcomes and patient stratification;
- Encourage and enable interdisciplinary collaborations by combining pre-clinical and clinical research in translational projects, and multi-actor research by engaging a range of other relevant disciplines such as bioinformatics/health informatics/data research, ELSA research, implementation research or health economicsresearch connected to the proposed research topic, including end-user perspective analysis to empower the implementation of PM
- Encourage cross-sectorial collaborations, by including the private sector (e.g. SMEs, small and medium-sized enterprises), industry, as well as regulatory/HTA agencies and patient organisations.
- Research projects in all disease areas are encouraged. Consortia are required to start from a relevant clinical (unmet) need and to include activities that support a comprehensive and efficient uptake of the developed PM approach in clinical practice, with the aim that “Today’s research is tomorrow’s healthcare”.
Consortium
Companies and research organizations can participate in this call as part of an international consortium. According to the call guidelines, Business Finland can finance a maximum of two Finnish organizations from one consortium. We encourage especially companies to participate in consortia. The results of the public research project must have broad applicability in business. Depending on the Finnish organizations applying in the consortium, Business Finland uses Co-Innovation or Co-Research funding services.
- Co-Innovation: Read more about the requirements. Exceptionally, one Finnish research organization and one Finnish company can form a Co-Innovation consortium in this call. Also Finnish companies and their projects applying for funding are evaluated using the Co-Innovation guidelines.
Co-Research: Read more about the requirements. Applications from a research organization (with no Finnish company in the consortium) or two research organizations are evaluated using the Co-Research guidelines. Companies that could utilize the results must contribute to the financing of the research organizations project (at least 10 % from the Finnish research organizations budget).
Please be in contact with a Business Finland contact person before sending the applications! In addition to following the JTC2024 guidelines, the applicants and projects need to follow the Business Finland funding terms and guidelines which can be found in the Business Finland website.
Preliminary schedule
The call is two-phased:
- Deadline for pre-proposal submission 5.3.2024.
- Communication of the results of the pre-proposal assessment and invitation to the full-proposal stage (project coordinator) around May 20th.
- Deadline for full-proposal submission
- Communication of the funding decisions to the applicants by the end of 2024
- Expected project start end of 2024/beginning of 2025
Electronic proposals are submitted using the EP PerMed submission portal
Finnish participants submit a separate application for Business Finland in the second phase of the call. Eligible applicants will be notified. More information about the call and Business Finland requirements:
Submission portal
Funding terms
